Sugi Predict

Sugi Predict / Compounds / SCHEMBL346311

SCHEMBL346311

SCHEMBL346311

CC(C)(C)OC(=O)NC(CCCc1ccccc1)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 6/20 0.63
▸ CTSS P25774 4/20 0.61
▸ PPARA Q07869 5/20 0.59
▸ PPARG P37231 4/20 0.59
▸ ACE P12821 1/20 0.58
▸ CTSL P07711 1/20 0.54
▸ CTSB P07858 1/20 0.54
▸ PPARD Q03181 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ MMP1 P03956 2/20 0.52
▸ MMP3 P08254 2/20 0.52
▸ MMP9 P14780 2/20 0.52
▸ ATM Q13315 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1374859 1.00 CTSK (0.63) CTSKCTSSPPARAPPARGACE
SCHEMBL2781406 1.00 CTSK (0.63) CTSKCTSSPPARAPPARGACE
SCHEMBL2856837 0.96 CTSK (0.61) CTSKCTSSPPARAPPARGACE
SCHEMBL2856841 0.96 CTSK (0.61) CTSKCTSSPPARAPPARGACE
SCHEMBL23176943 0.95 CTSK (0.60) CTSKCTSSPPARAPPARGACE
SCHEMBL24814896 0.95 CTSK (0.60) CTSKCTSSPPARAPPARGACE
SCHEMBL24814889 0.95 CTSK (0.60) CTSKCTSSPPARAPPARGACE
SCHEMBL23177045 0.95 CTSK (0.60) CTSKCTSSPPARAPPARGACE
SCHEMBL181807 0.92 CTSK (0.71) CTSKCTSSPPARAPPARGACE
SCHEMBL181775 0.92 CTSK (0.71) CTSKCTSSPPARAPPARGACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117561058-A CDK2 inhibitors and methods of use thereof 塞迪拉治疗股份有限公司 2024-02-13 — — CN disclosed
CN-116640072-A Method for synthesizing oxime compound by catalyzing hydrocarbon bond oxidation through tetradentate nitrogen-containing coordination manganese 陕西师范大学 2023-08-25 — — CN disclosed
US-8791102-B2 Acetanilide sphingosine-1-phosphate receptor antagonists EXELIXIS, INC. (US) 2014-07-29 — — US disclosed
US-8338471-B2 (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors MEDIVIR AB (SE) 2012-12-25 — — US disclosed
US-20120015994-A1 (2,5-DIOXOIMIDAZOLIDIN-I-YL)-N-HYDROXY-ACETAMIDES AS METALLOPROTEINASE INHIBITORS MEDIVIR AB (SE) 2012-01-19 — — US disclosed
US-20110288076-A1 Sphingosine-1-Phosphate Receptor Antagonists EXELIXIS, INC. (US) 2011-11-24 — — US disclosed
CN-102256944-A Sphingosine-1-phosphate receptor antagonists EXELIXIS INC 2011-11-23 — — CN disclosed
US-8022092-B2 (2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors MEDIVIR AB (SE) 2011-09-20 — — US disclosed
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 — — EP disclosed
US-20100311798-A1 2-AMINOOXAZOLINES AS TAAR1 LIGANDS HOFFMANN-LA ROCHE, INC. 2010-12-09 — — US disclosed
US-5492916-A Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone MERCK & CO., INC. (US) 1996-02-20 — — US disclosed
WO-1996002530-A1 PIPERIDINES AND HEXAHYDRO-1H-AZEPINES SPIRO SUBSTITUTED AT THE 4-POSITION PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1996-02-01 — — WO disclosed
EP-0662481-A1 Spiro piperidines and homologs promote release of growth hormone MERCK & CO. INC. (US) 1995-07-12 — — EP disclosed
WO-1995013069-A1 PIPERIDINES, PYRROLIDINES AND HEXAHYDRO-1H-AZEPINES PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1995-05-18 — — WO disclosed
EP-0644772-A1 OPIOID PEPTIDES BIOMEASURE, INC. (US) 1995-03-29 — — EP disclosed
CN-1092767-A Promote spiroperidol and homologue that tethelin discharges MERCK & CO INC (US) 1994-09-28 — — CN disclosed
WO-1994019367-A1 SPIRO PIPERIDINES AND HOMOLOGS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1994-09-01 — — WO disclosed
WO-1994011018-A1 OPIOID PEPTIDES BIOMEASURE, INC. (US) 1994-05-26 — — WO disclosed
WO-1994007815-A2 SMALL PEPTIDE ANAPHYLATOXIN RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 1994-04-14 — — WO disclosed
EP-0352000-A2 Retroviral protease binding peptides SMITHKLINE BEECHAM CORPORATION (US) 1990-01-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311798-A1 2-AMINOOXAZOLINES AS TAAR1 LIGANDS TAAR1, TAAR5, NPY2R CTSK 2354/4885CTSS 3355/4885PPARA 1384/4885
US-20120015994-A1 (2,5-DIOXOIMIDAZOLIDIN-I-YL)-N-HYDROXY-ACETAMIDES AS METALLOPROTEINASE INHIBITORS MMP12, MMP13, MMP14 CTSK 417/4885CTSS 186/4885PPARA 1865/4885
US-20110288076-A1 Sphingosine-1-Phosphate Receptor Antagonists S1PR1, S1PR2, S1PR3 CTSK 3023/4885CTSS 3141/4885PPARA 1880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.